Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ISA 2020 | AL amyloidosis during the pandemic

Giampaolo Merlini, MD, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy, talks on AL amyloidosis management during the pandemic, specifically highlighting the fragility of this patient population and how telemedicine can avoid unnecessary contact. Prof. Merlini goes on to discuss the difficulties being faced in terms of trial conduction due to COVID-19. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).